Format

Send to

Choose Destination
See comment in PubMed Commons below
Cancer Lett. 2014 Apr 10;345(2):258-70. doi: 10.1016/j.canlet.2013.08.013. Epub 2013 Aug 24.

Gastrointestinal cancers: influence of gut microbiota, probiotics and prebiotics.

Author information

1
"Iuliu Hatieganu" University of Medicine and Pharmacy, Second Pediatric Clinic, Emergency Children's Hospital, Cluj-Napoca, Romania. Electronic address: danitiserban@yahoo.com.

Abstract

Cancers of the gastrointestinal (GI) tract continue to represent a major health problem, despite progress in therapy. Gut microbiota is a key element related to the genesis of GI cancers, countless papers addressing this burning issue across the world. We provide an updated knowledge of the involvement of gut microbiota in GI tumorigenesis, including its underlying mechanisms. We present also a comprehensive review of the evidence from animal and clinical studies using probiotics and/or prebiotics in the prevention and/or therapy of GI tumours, of GI cancer therapy-related toxicity and of post-operative complications. We summarize the anticarcinogenic mechanisms of these biotherapeutics from in vitro, animal and clinical interventions. More research is required to reveal the interactions of microflora with genetic, epigenetic and immunologic factors, diet and age, before any firm conclusion be drawn. Well-designed, randomized, double blind, placebo-controlled human studies using probiotics and/or prebiotics, with adequate follow-up are necessary in order to formulate directions for prevention and therapy.

KEYWORDS:

Dysbiosis; Gastrointestinal cancer; Gut microflora; Prebiotics; Probiotics

PMID:
23981580
DOI:
10.1016/j.canlet.2013.08.013
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center